Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Paradise818on Jun 29, 2017 1:42am

172 Views

Post# 26417654

RE:Questions for management

I can give you an idea why. The TLC2000 is only approved for use on a specific knee condition. Having spent the past 25 years in the therapy field and looked at purchasing various lasers, I wouldn't spend the money if that's all I could treat. If and when the TLC2000 is approved for other body parts and efficacy demonstrated, I can't see the numbers significantly increasing.

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season